Catalyst Wire Dossier Catalyst Wire Dossier

darbepoetin alfa

darbepoetin alfa
Drug timelines are a Plus or Pro feature.

53 regulatory and trial events tracked for darbepoetin alfa, covering 2006-07-07 to 2025-09-24. Get the full timeline:

Most recent: Clinical Trial Update: Darbepoetin Alfa Once Monthly Dosing Schedule Maintains Hemoglobin Concentration Comparable to Every 2 Weeks Dosing Schedule in Advanced Chronic Kidney Disease Patients Not on Dialysis: A Multicenter, Phase 4 Study [Phase 4]

See pricing